Jane Street
UBX

Jane Street’s Unity Biotechnology UBX Stock Holding History

Jane Street’s Portfolio UBX Stock Details UBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-21,179
Closed -$20.7K – 10651
2024
Q4 		$20.7K Buy
+21,179
New +$26.3K ﹤0.01% 9128
2024
Q1 		– Sell
-28,455
Closed -$54.9K – 10103
2023
Q4 		$54.9K Buy
28,455
+11,360
+66% +$21.1K ﹤0.01% 8763
2023
Q3 		$41K Buy
+17,095
New +$45.3K ﹤0.01% 8194
2023
Q1 		– Sell
-13,460
Closed -$36.9K – 9961
2022
Q4 		$36.9K Buy
+13,460
New +$39.1K ﹤0.01% 8455
2022
Q1 		– Sell
-4,321
Closed -$63K – 11049
2021
Q4 		$63K Buy
+4,321
New +$94.4K ﹤0.01% 9450
2021
Q3 		– Sell
-2,166
Closed -$100K – 10757
2021
Q2 		$100K Buy
+2,166
New +$104K ﹤0.01% 9266
2021
Q1 		– Sell
-10,291
Closed -$539K – 9611
2020
Q4 		$539K Buy
10,291
+6,044
+142% +$291K ﹤0.01% 5617
2020
Q3 		$147K Buy
+4,247
New +$269K ﹤0.01% 6607

Other funds holding UBX

FH
Financial Harvest Winter Park, Florida $170M AUM 20.71% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
FFVM
Founders Fund V Management San Francisco, California $2.16M AUM 77.37% 1-Year Est. Return

Jane Street's UBX Position: Q1 2025 in Review

Jane Street sold out of Unity Biotechnology (UBX) in Q1 2025, closing a stake of 21,179 shares — an estimated $20.7K sold.

Jane Street first reported a position in UBX in Q3 2020 and held it in 8 quarters. The position peaked at $539K in Q4 2020. 40 funds tracked by Wall St. Rank hold UBX as of Q1 2025.

  • Jane Street reported no remaining Unity Biotechnology position as of Q1 2025 after selling out during the quarter.
  • Jane Street sold 21,179 Unity Biotechnology shares in Q1 2025, an estimated $20.7K.
  • Jane Street first reported a position in Unity Biotechnology in Q3 2020 and held it in 8 quarters.
  • Jane Street's Unity Biotechnology position peaked at $539K in Q4 2020.
  • 40 funds tracked by Wall St. Rank held Unity Biotechnology as of Q1 2025.

Based on Jane Street's 13F filing for Q1 2025, filed 14 May 2025.